VIVAGUARD
Live / Registered — Registered — Section 8 accepted (as of 02 May 2025)
What this means for you
Registered since 11 Dec 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87651114
- Registration number
- 5625412
- Mark type
- Stylized text
- Filed
- 18 Oct 2017
- Published for opposition
- 25 Sept 2018
- Registered
- 11 Dec 2018
- Attorney of record
- Roman Campos
Goods and services
- Class 005 — Pharmaceuticals: diagnostic test strips for determining the level of glucose in blood for medical and clinical use; control solutions for medical and clinical use for quality checks on blood glucose monitors, and diagnostic test strips for testing cells, blood and blood components
- Class 010 — Medical apparatus: blood glucose monitors being a device for monitoring blood glucose for medical purposes, medical lancing devices, lancets; blood glucose monitoring kits comprising a blood glucose monitor, medical lancing devices, lancets diagnostic test strips and control solutions, for monitoring blood glucose for medical purposes
Owner
- VIVACHEK BIOTECH (HANGZHOU) CO., LTD., HANGZHOU, CN
- Able Diagnostics, Inc., San Diego, CA, US
- Able Diagnostics, Inc., San Diego, CA, US
- Able Diagnostics, Inc., San Diego, CA, US
Prosecution history
- 02 May 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 02 May 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 02 May 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 22 Nov 2024 — TEAS SECTION 8 RECEIVED
- 16 May 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 11 Dec 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 11 Dec 2018 — REGISTERED-PRINCIPAL REGISTER
- 25 Sept 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Sept 2018 — PUBLISHED FOR OPPOSITION
- 05 Sept 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Aug 2018 — ASSIGNED TO LIE
- 07 Aug 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Aug 2018 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 31 Jul 2018 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 31 Jul 2018 — TEAS RESPONSE TO OFFICE ACTION RECEIVED